Bristol-Myers (BMY) announces an additional $3B share repurchase program, adding to its already...


Bristol-Myers (BMY) announces an additional $3B share repurchase program, adding to its already current, active $3B repurchase program currently underway, of which it has approximately $340M remaining. This brings its total authorized buyback to approximately $6B. Shares +0.5% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs